United Kingdom

BMI View: While it is difficult to gauge the precise amount drugmakers spend on marketing activities, it is clear that drug companies' marketing budgets are worth... 2013-02-07

BMI View: The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan... 2013-01-28

BMI View: The UK has a strong domestic pharmaceuticals industry representing a considerable force in the international market. Leading players GSK and AstraZeneca enjoy high market... 2013-01-22

BMI View: For innovative drugmakers, the importance of maintaining healthy research and development (R&D) pipelines and launching new drugs cannot be stressed enough.... 2013-01-14

BMI View: The UK's pharmaceutical industry does not employee a large proportion of the local labour force. Nevertheless, the closure of sites by multinational drugmakers during the... 2012-12-04

BMI View: Drugs for high prevalence disease such as diabetes that offer fewer side-effects, work more efficiently than available therapeutics and can show advanced cost-effectiveness... 2012-11-29

BMI View: Vaccines can be an extremely cost-effective form of medical care. They help to slow or prevent the spread of diseases and reduce overall healthcare expenditure. However,... 2012-11-22